肺癌胰腺转移的临床特点及预后分析
背景与目的由于缺乏特异的临床症状,70%的肺癌患者确诊时为局部晚期或晚期,多数患者伴有实性器官转移,不同部位转移患者的临床表现及预后不同。随着诊断技术的发展,肺癌伴胰腺转移似有逐渐增多趋势。本研究针对肺癌胰腺转移的临床特点、诊治、预后及生存情况进行统计分析,探讨肺癌胰腺转移的相关预后因素。方法回顾性分析1996年7月-2017年6月于北京肿瘤医院胸部肿瘤内一科就诊的35例经病理确诊的肺癌并胰腺转移或在治疗过程中出现胰腺转移的患者,其中33例有完整随访资料。结果 35例患者中,小细胞肺癌28例(80%),腺癌3例(8.6%),鳞癌4例(11.4%)。初治时即存在胰腺转移者21例(60%),14例...
Saved in:
Published in | 中国肺癌杂志 Vol. 20; no. 8; pp. 511 - 515 |
---|---|
Main Author | |
Format | Journal Article |
Language | Chinese |
Published |
中国医学科学院肿瘤医院肿瘤内科, 北京,100021%南平市人民医院肿瘤内科, 南平,353000%北京大学临床肿瘤学院北京肿瘤医院 胸部肿瘤内一科, 北京,100142
2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1009-3419 1999-6187 |
DOI | 10.3779/j.issn.1009-3419.2017.08.02 |
Cover
Summary: | 背景与目的由于缺乏特异的临床症状,70%的肺癌患者确诊时为局部晚期或晚期,多数患者伴有实性器官转移,不同部位转移患者的临床表现及预后不同。随着诊断技术的发展,肺癌伴胰腺转移似有逐渐增多趋势。本研究针对肺癌胰腺转移的临床特点、诊治、预后及生存情况进行统计分析,探讨肺癌胰腺转移的相关预后因素。方法回顾性分析1996年7月-2017年6月于北京肿瘤医院胸部肿瘤内一科就诊的35例经病理确诊的肺癌并胰腺转移或在治疗过程中出现胰腺转移的患者,其中33例有完整随访资料。结果 35例患者中,小细胞肺癌28例(80%),腺癌3例(8.6%),鳞癌4例(11.4%)。初治时即存在胰腺转移者21例(60%),14例治疗过程中出现胰腺转移(40%)。在胰腺转移灶中,胰头转移者15例(42.9%),胰腺体尾部转移者20例(57.1%),单发转移23例(65.7%),多发转移12例(34.3%)。肺癌胰腺转移患者多无明显临床症状,本组病例中,仅4例患者在病程中出现胰腺炎症状。病理类型是影响肺癌胰腺转移患者生存的独立预后因素。结论部分晚期肺癌患者可以出现胰腺转移,多见于小细胞肺癌。肺癌患者出现胰腺转移,治疗原则以全身化疗为主的综合治疗。病理类型是影响肺癌胰腺转移患者生存的独立预后因素。 |
---|---|
Bibliography: | Jianchun DUAN1, Rui WAN1, Jianqin SHEN2, Xuyi LIU3, Jie WANG1, Jun ZHAO3, Meina WU3, Lu YANG3, Tongtong AN3, Ojngzhi GUO3 (1Department of Oncology, Cancer Hospital Chinese Academical of Medical Science, Beijing 100021, China; 2Department of Ontology, The People Hospital of Nanping, Nanping 353000, China; 3The First Department of Thoracic Oncology, Beijing University School of Oncology, Beijing Cancer Hospital, Beijing 100142, China) Background and objective Lacking of typical symptoms, more than 70% of patients with lung cancer are diagnosed as advanced-stage disease. Patients suffer from solid organs metastasis with different clinical features and prognosis. With development of new technology, more and more lung cancer patients are diagnosed with pancreatic metastasis. The aim of this study was to investigate clinicopathologic and survival difference by retrospective analysis among lung cancer patients with pancreatic metastases. Methods Of the patients with lung cancer diagnosed by pathology and thorough sta |
ISSN: | 1009-3419 1999-6187 |
DOI: | 10.3779/j.issn.1009-3419.2017.08.02 |